Phillipe D. O’Brien

1.6k total citations · 1 hit paper
22 papers, 1.3k citations indexed

About

Phillipe D. O’Brien is a scholar working on Physiology, Molecular Biology and Epidemiology. According to data from OpenAlex, Phillipe D. O’Brien has authored 22 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 10 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Phillipe D. O’Brien's work include Adipose Tissue and Metabolism (12 papers), Pain Mechanisms and Treatments (7 papers) and Diet and metabolism studies (4 papers). Phillipe D. O’Brien is often cited by papers focused on Adipose Tissue and Metabolism (12 papers), Pain Mechanisms and Treatments (7 papers) and Diet and metabolism studies (4 papers). Phillipe D. O’Brien collaborates with scholars based in United States, Sweden and Ireland. Phillipe D. O’Brien's co-authors include Eva L. Feldman, Lucy M. Hinder, Stacey A. Sakowski, Brian C. Callaghan, John M. Hayes, Junguk Hur, Carey Backus, Ned Buyukmihci, Geoffrey K. Aguirre and Amy E. Rumora and has published in prestigious journals such as Diabetes, Scientific Reports and The Lancet Neurology.

In The Last Decade

Phillipe D. O’Brien

22 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neurological consequences of obesity

2017 363 citations Phillipe D. O’Brien, Lucy M. Hinder et al. The Lancet Neurology profile →

Peers

Countries citing papers authored by Phillipe D. O’Brien

Since Specialization

Citations

This map shows the geographic impact of Phillipe D. O’Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillipe D. O’Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillipe D. O’Brien more than expected).

Fields of papers citing papers by Phillipe D. O’Brien

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillipe D. O’Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillipe D. O’Brien. The network helps show where Phillipe D. O’Brien may publish in the future.

Co-authorship network of co-authors of Phillipe D. O’Brien

This figure shows the co-authorship network connecting the top 25 collaborators of Phillipe D. O’Brien. A scholar is included among the top collaborators of Phillipe D. O’Brien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillipe D. O’Brien. Phillipe D. O’Brien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dietary interventions improve diabetic kidney disease, but not peripheral neuropathy, in a db/db mouse model of type 2 diabetes 2023 ·The FASEB Journal ·Stéphanie Eid, Phillipe D. O’Brien, (unknown), (unknown), Faye E. Mendelson, John M. Hayes, (unknown), Hongyu Zhang, Subramaniam Pennathur, Frank C. Brosius, (unknown), Eva L. Feldman	8
2	A High-Fat Diet Disrupts Nerve Lipids and Mitochondrial Function in Murine Models of Neuropathy 2022 ·Frontiers in Physiology ·Amy E. Rumora, Kai Guo, Lucy M. Hinder, Phillipe D. O’Brien, John M. Hayes, Junguk Hur, Eva L. Feldman	19
3	Glucagon-Like Peptide-1 Receptor Agonist Use in People Living with Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Narrative Review of the Key Evidence with Practical Considerations 2022 ·Diabetes Therapy ·José Luis Górriz, Irene Romera, (unknown), Phillipe D. O’Brien, Juan Francisco Merino-Torres	12
4	Differential effects of minocycline on microvascular complications in murine models of type 1 and type 2 diabetes 2021 ·Journal of Translational Science ·Stéphanie Eid, Phillipe D. O’Brien, Lucy M. Hinder, John M. Hayes, Faye E. Mendelson, Hongyu Zhang, Samanthi Narayanan, Steven F. Abcouwer, Frank C. Brosius, Subramaniam Pennathur, Masha G. Savelieff, Eva L. Feldman	7
5	Sex differences in insulin resistance, but not peripheral neuropathy, in a diet-induced prediabetes mouse model 2021 ·Disease Models & Mechanisms ·Sarah E. Elzinga, Masha G. Savelieff, Phillipe D. O’Brien, Faye E. Mendelson, John M. Hayes, Eva L. Feldman	27
6	Differential Effects of Empagliflozin on Microvascular Complications in Murine Models of Type 1 and Type 2 Diabetes 2020 ·Biology ·Stéphanie Eid, Phillipe D. O’Brien, Lucy M. Hinder, John M. Hayes, Faye E. Mendelson, Hongyu Zhang, Lixia Zeng, (unknown), Samanthi Narayanan, Steven F. Abcouwer, Frank C. Brosius, Subramaniam Pennathur, Masha G. Savelieff, Eva L. Feldman	24
7	Integrated lipidomic and transcriptomic analyses identify altered nerve triglycerides in mouse models of prediabetes and type 2 diabetes 2019 ·Disease Models & Mechanisms ·Phillipe D. O’Brien, Kai Guo, Stéphanie Eid, Amy E. Rumora, Lucy M. Hinder, John M. Hayes, Faye E. Mendelson, Junguk Hur, Eva L. Feldman	53
8	Temporal evolution of the microbiome, immune system, and epigenome with disease progression in ALS mice 2019 ·Disease Models & Mechanisms ·Claudia Figueroa‐Romero, Kai Guo, Benjamin J. Murdock, Ximena Paez-Colasante, Christine M. Bassis, (unknown), (unknown), Matthew C. Evans, (unknown), Andrew J. McDermott, Phillipe D. O’Brien, Masha G. Savelieff, Junguk Hur, Eva L. Feldman	70
9	Mitochondrial uncoupling has no effect on microvascular complications in type 2 diabetes 2019 ·Scientific Reports ·Lucy M. Hinder, Kelli M. Sas, Phillipe D. O’Brien, Carey Backus, Pradeep Kayampilly, John M. Hayes, Cheng‐mao Lin, Hongyu Zhang, (unknown), Amy E. Rumora, Steven F. Abcouwer, Frank C. Brosius, Subramaniam Pennathur, Eva L. Feldman	22
10	Transcriptional networks of progressive diabetic peripheral neuropathy in the db/db mouse model of type 2 diabetes: An inflammatory story 2018 ·Experimental Neurology ·Lucy M. Hinder, Benjamin J. Murdock, (unknown), Diane E. Bender, Phillipe D. O’Brien, Amy E. Rumora, Junguk Hur, Eva L. Feldman	47
11	Juvenile murine models of prediabetes and type 2 diabetes develop neuropathy 2018 ·Disease Models & Mechanisms ·Phillipe D. O’Brien, Lucy M. Hinder, Amy E. Rumora, John M. Hayes, Jacqueline R. Dauch, Carey Backus, Faye E. Mendelson, Eva L. Feldman	37
12	Amelioration of Peripheral Neuropathy in Mouse Models of Diabetes by Dietary Reversal 2018 ·Diabetes ·Phillipe D. O’Brien, Kai Guo, Lucy M. Hinder, John M. Hayes, Faye E. Mendelson, (unknown), Junguk Hur, Eva L. Feldman	1
13	Neurological consequences of obesity breakdown → 2017 ·The Lancet Neurology ·Phillipe D. O’Brien, Lucy M. Hinder, Brian C. Callaghan, Eva L. Feldman	363
14	Dual CCR2 / CCR5 antagonist treatment attenuates adipose inflammation, but not microvascular complications in ob/ob mice 2017 ·Diabetes Obesity and Metabolism ·Phillipe D. O’Brien, Lucy M. Hinder, Sebastian D. Parlee, John M. Hayes, Carey Backus, Hongyu Zhang, Li‐Jun Ma, Stacey A. Sakowski, Frank C. Brosius, Eva L. Feldman	17
15	Dietary reversal of neuropathy in a murine model of prediabetes and the metabolic syndrome 2017 ·Disease Models & Mechanisms ·Lucy M. Hinder, Phillipe D. O’Brien, John M. Hayes, Carey Backus, (unknown), Catrina Sims‐Robinson, Eva L. Feldman	65
16	Transcriptional networks of murine diabetic peripheral neuropathy and nephropathy: common and distinct gene expression patterns 2016 ·Diabetologia ·Junguk Hur, Phillipe D. O’Brien, Viji Nair, Lucy M. Hinder, (unknown), H. V. Jagadish, Matthias Kretzler, Frank C. Brosius, Eva L. Feldman	34
17	Gender-specific differences in diabetic neuropathy in BTBR ob/ob mice 2015 ·Journal of Diabetes and its Complications ·Phillipe D. O’Brien, Junguk Hur, (unknown), John M. Hayes, Stacey A. Sakowski, Eva L. Feldman	38
18	ER Stress in Diabetic Peripheral Neuropathy: A New Therapeutic Target 2014 ·Antioxidants and Redox Signaling ·Phillipe D. O’Brien, Lucy M. Hinder, Stacey A. Sakowski, Eva L. Feldman	71
19	Mouse Models of Diabetic Neuropathy 2014 ·ILAR Journal ·Phillipe D. O’Brien, Stacey A. Sakowski, Eva L. Feldman	185
20	TPCK-induced apoptosis and labelling of the largest subunit of RNA polymerase II in Jurkat cells 2009 ·APOPTOSIS ·Zsolt Fábián, Phillipe D. O’Brien, (unknown), Howard O. Fearnhead	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact